Latest filing published 15 Dec 2023 for Enanta Pharmaceuticals INC, €129k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +4.9%Entry US$27.82 · Close at T+365 US$29.17
- +100.4%Entry US$19.96 · Close at T+365 US$39.99
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Terry Vance: trading record in brief
Terry Vance is a declared insider of Enanta Pharmaceuticals Inc, with filings sourced from SEC (Form 4). Over a trading history stretching from 26 March 2013 to 13 December 2023, the count stands at 4 filings.
In open-market terms, that means 2 purchases worth €193k on one side and 1 sale worth €129k on the other. Taken together, the purchases exceed the sales by €63k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 1 option exercise. In 2023 alone, the filings show no purchases and 1 sale.
On 15 December 2023 came the latest disclosure, an open-market sale for €129k in Enanta Pharmaceuticals Inc. The most recent open-market purchase was published on 17 February 2016, 3,917 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Terry Vance
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 15,295 shares@ US$9.1262.7% of flowCommon StockSEC:0001062993-23-022695:0
- 5,800 shares@ US$14.0037.3% of flowCommon StockSEC:0001062993-23-007225:0
- 2,000 shares@ US$27.0418.8% of flowCommon StockSEC:0000908662-16-000460:0Canonical exit: 12 May 2016 (T+90)
- 13,295 shares@ US$14.00Common StockSEC:0000908662-13-000160:0Canonical exit: 24 Jun 2013 (T+90)
4 of 4 declarations